{"disease":{"id":"methicillin-resistant-staphylococcus-aureus","name":"methicillin resistant staphylococcus aureus"},"drugs":{"marketed":[{"drug_id":"daptomycin","indication_name":"Sepsis caused by methicillin resistant Staphylococcus aureus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cubicin","generic_name":"Daptomycin","company_name":"Baxter","drug_phase":"marketed","molecular_target":"","drug_class":"lipopeptide antibacterial","quality_score":59,"revenue":null,"mechanism":"Daptomycin is an antibacterial drug with lipopeptide structure."},{"drug_id":"mupirocin","indication_name":"Methicillin-Resistant Staphylococcus Aureus Nasal Colonization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bactroban","generic_name":"MUPIROCIN","company_name":"GSK","drug_phase":"marketed","molecular_target":"Isoleucine--tRNA ligase, cytoplasmic","drug_class":"RNA Synthetase Inhibitor Antibacterial","quality_score":75,"revenue":null,"mechanism":"Bactroban works by inhibiting the production of essential proteins in bacteria, preventing them from reproducing and causing infection."},{"drug_id":"cubicin","indication_name":"Sepsis caused by methicillin resistant Staphylococcus aureus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cubicin","company_name":"Clinical Alliance for Research & Education - Infectious Diseases, LLC.","drug_phase":"marketed","molecular_target":"Outer membrane porin protein OmpD","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"dapt","indication_name":"Sepsis caused by methicillin resistant Staphylococcus aureus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DAPT","company_name":"Baxter Hlthcare Corp","drug_phase":"marketed","molecular_target":"Outer membrane porin protein OmpD","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03064464","title":"CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome","phase":"","overall_status":"UNKNOWN","enrollment_count":5400,"lead_sponsor_name":"Sir Run Run Shaw Hospital","has_results":false},{"nct_id":"NCT02365493","title":"Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":358,"lead_sponsor_name":"Menzies School of Health Research","has_results":false},{"nct_id":"NCT03637400","title":"Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":269,"lead_sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","has_results":false},{"nct_id":"NCT01350479","title":"Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers","phase":"","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT02814916","title":"Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05529173","title":"Povidone-Iodine for Nasal Decolonization","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":192,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":true},{"nct_id":"NCT01817075","title":"Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT06959667","title":"Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":144,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT04171817","title":"Animal-Assisted Visitation Program Chlorhexidine Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT01855048","title":"A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Intron Biotechnology, Inc.","has_results":true},{"nct_id":"NCT03446053","title":"A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Intron Biotechnology, Inc.","has_results":true},{"nct_id":"NCT00324922","title":"Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"University of Washington","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}